A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia

被引:0
|
作者
Fadaii, F. [1 ]
机构
[1] Univ Social Welf, Tehran, Iran
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S131 / S132
页数:2
相关论文
共 50 条
  • [1] A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia
    Niknam, Z.
    Fadaii, F.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S280 - S281
  • [2] A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for the cognitive impairment of schizophrenia
    Tugal, O
    Yazici, KM
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S295 - S295
  • [3] A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia
    Tugal, O
    Yazici, KM
    Yagcioglu, AEA
    Gogus, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (02): : 117 - 123
  • [4] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (05) : 349 - 357
  • [5] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 9 - 9
  • [6] A randomised, double-blind, placebo controlled, cross-over trial of adjunctive L-arginine in schizophrenia
    Kocyigit, Y.
    Ayhan, Y.
    Yoca, G.
    Karahan, S.
    Yazici, M. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S484 - S484
  • [7] Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind placebo controlled cross-over trial
    de Boer, M. K.
    Oolders, H.
    Schoevers, R. A.
    Wiersma, D.
    Knegtering, H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S487 - S488
  • [8] Modulation of Hippocampal Hyperactivity in Schizophrenia With Levetiracetam: a Randomized, Double-Blind, Cross-Over, Placebo-Controlled Trial
    Roeske, Maxwell
    McHugo, Maureen
    Rogers, Baxter
    Avery, Suzanne
    Armstrong, Kristan
    Heckers, Stephan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 350 - 351
  • [9] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Roeske, Maxwell J.
    Mchugo, Maureen
    Rogers, Baxter
    Armstrong, Kristan
    Avery, Suzanne
    Donahue, Manus
    Heckers, Stephan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2024, 49 (04) : 681 - 689
  • [10] Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial
    Oliver Freudenreich
    Lawrence Herz
    Thilo Deckersbach
    A. Eden Evins
    David C. Henderson
    Corinne Cather
    Donald C. Goff
    [J]. Psychopharmacology, 2005, 181 : 358 - 363